UPDATE : Saturday, March 28, 2020
상단여백
Stricter quarantine for new arrivals may expand to all regions by Shim Hyun-tai 2020-03-23 14:46
‘Coronavirus will die hard. Embrace the new normal’ by Kwak Sung-sun 2020-03-23 14:41
Daewoong to market Genomictree's colon cancer diagnostic kit by Lee Han-soo 2020-03-23 11:59
SK Bioscience starts animal trial of COVID-19 vaccine by Lee Han-soo 2020-03-23 11:52
Amid subdued new cases, Korea alert on cluster infections, foreign influxes by Lee Han-soo 2020-03-22 12:21
라인
Controversy goes on over cause of high school boy’s death by Shim Hyun-tai 2020-03-20 19:42
[Column] Are we ready for COVID-19’s arrival at schools? by Korea Biomedical Review 2020-03-20 18:21
[Up-and-coming medical startups of 2020] CES 2020 award-winning startup Exosystems unveils ‘exoRehab’ by Shim Hyun-tai 2020-03-20 18:09
‘Managing Parkinson’s disease gets more elaborate after deep brain stimulation’ by Lee Han-soo 2020-03-20 18:09
Laparoscopic treatment developed for resistant hypertension by Choi Gwang-seok 2020-03-20 18:08
라인
Korea struggles to secure supply of rare drugs amid COVID-19 by Lee Han-soo 2020-03-20 16:54
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod by Lee Han-soo 2020-03-20 16:52
New COVID-19 cases fall back to 100 as quarantine tightened at airports by Shim Hyun-tai 2020-03-20 14:22
Optimal third-line therapy found for type 2 diabetes by Lee Han-soo 2020-03-20 12:34
Macrogen reports profit drop in 2019 by Lee Han-soo 2020-03-20 12:34
라인
Peptron’s trial of Parkinson’s disease treatment in full swing by Shim Hyun-tai 2020-03-20 11:31
‘Shincheonji members working at call center might need antibody testing’ by Song Soo-youn 2020-03-20 11:23
Novo Nordisk's Saxenda remains world’s top obesity treatment by Shim Hyun-tai 2020-03-19 17:59
Korea’s evolving virus tests -- from drive-through to walk-through by Shim Hyun-tai 2020-03-19 17:17
‘US agency's COVID-19 test based on easily mutated gene’ by Song Soo-youn 2020-03-19 17:13
-12345678910-
여백
Fully cured patients exceed those under treatment in KoreaFully cured patients exceed those under treatment in Korea
여백
Most viewed
여백
Opinion
[Column] Are we ready for COVID-19’s arrival at schools?
[Column] Are we ready for COVID-19’s arrival at schools?
[Column] Temporary nod for telemedicine against COVID-19 too hasty 
[Column] Temporary nod for telemedicine against COVID-19 too hasty 
[Column] Will ‘third wave’ of COVID-19 hit Korea?
[Column] Will ‘third wave’ of COVID-19 hit Korea?
여백
Back to Top